<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T01:30:08Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10256/19867" metadataPrefix="marc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10256/19867</identifier><datestamp>2024-05-22T11:27:49Z</datestamp><setSpec>com_2072_452966</setSpec><setSpec>com_2072_2054</setSpec><setSpec>col_2072_452968</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
   <leader>00925njm 22002777a 4500</leader>
   <datafield ind2=" " ind1=" " tag="042">
      <subfield code="a">dc</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Maroto Morales, Daniel</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2020-11</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">BACKGROUND: Skin diseases may modify epidermal barrier function. Psoriasis is a&#xd;
chronic multi-systemic inflammatory disease that may affects the epidermal barrier.&#xd;
Emollients are an option as a coadjutant therapy for psoriasis management, but little is&#xd;
known about how epidermal barrier function is modified by moisturizers administration&#xd;
in psoriatic patients.&#xd;
HYPOTHESIS AND OBJECTIVES: The objective of this before-and-after study is to analyse&#xd;
skin homeostasis and epidermal barrier function differences between psoriatic plaque,&#xd;
non-affected skin in psoriatic patients and control skin; also, to evaluate the effect of&#xd;
two types of moisturizers on psoriatic and healthy participants.&#xd;
METHODS: Thirty-one patients with plaque-type psoriasis and thirty-one gender and&#xd;
age-matched healthy controls were enrolled. Temperature, Transepidermal water loss&#xd;
(TEWL), stratum corneum hydration (SCH), pH, elasticity and erythema index were&#xd;
measured using non-invasive tools in the healthy control and involved and uninvolved&#xd;
psoriatic skin before and after the use of two determined moisturizers&#xd;
RESULTS: Healthy controls had lower TEWL, temperature, and higher pH levels than&#xd;
psoriatic patients. SCH levels were found lower in psoriatic plaques than in uninvolved&#xd;
and healthy skin (13,44 vs 30,55 vs 30,90 Arbitrary Units (AU); p&lt;0,001). TEWL was&#xd;
significantly higher in plaques than in psoriatic uninvolved skin (13,23 vs 8,54 g/h/m2;&#xd;
p&lt;0,001)., which was also higher than in control healthy skin (8,54 vs 6,41 g/h/m2;&#xd;
p=0,023).&#xd;
After emollients application on psoriatic plaques, SCH experimented a significant&#xd;
increment after the application of water-based formula (13,44 vs 22,89 AU; p=0,003).&#xd;
However, TEWL showed a decrease of 5,59 g/h/m2 (5,68 SD, p&lt;0,001) after use of&#xd;
Vaseline jelly; and the contrary effect after the water-formula application (increment of&#xd;
3,60 g/h/m2 (6,86 SD, p=0,006).&#xd;
CONCLUSION: Uninvolved psoriatic skin showed epidermal barrier dysfunction&#xd;
compared to healthy controls; in addition, psoriatic plaques barrier impairment was&#xd;
significantly higher than not-affected skin. Use of emollients may improve epidermal&#xd;
barrier function in psoriatic patients. SCH and TEWL parameters were the most changed&#xd;
after moisturizers application</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">http://hdl.handle.net/10256/19867</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Psoriasi</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Psoriasis</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Homeòstasi</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Homeostasis</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Epidermis</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Medicaments dermatològics</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Dermatologic agents</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Homeostasis and epidermal barrier analysis in psoriatic patients: the impact of emollients</subfield>
   </datafield>
</record></metadata></record></GetRecord></OAI-PMH>